Header Logo

Connection

David Bennett to Mice

This is a "connection" page, showing publications David Bennett has written about Mice.
Connection Strength

1.004
  1. Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis. Nat Commun. 2023 04 29; 14(1):2479.
    View in: PubMed
    Score: 0.039
  2. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 06 15; 17(1):42.
    View in: PubMed
    Score: 0.037
  3. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
    View in: PubMed
    Score: 0.036
  4. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies. Neurobiol Dis. 2021 12; 161:105542.
    View in: PubMed
    Score: 0.035
  5. Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice. Acta Neuropathol Commun. 2021 07 27; 9(1):129.
    View in: PubMed
    Score: 0.034
  6. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease. Nat Neurosci. 2021 06; 24(6):786-798.
    View in: PubMed
    Score: 0.034
  7. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2021 04 16; 16(1):26.
    View in: PubMed
    Score: 0.034
  8. PLD3 is a neuronal lysosomal phospholipase D associated with ?-amyloid plaques and cognitive function in Alzheimer's disease. PLoS Genet. 2021 04; 17(4):e1009406.
    View in: PubMed
    Score: 0.034
  9. A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease. Sci Transl Med. 2020 08 26; 12(558).
    View in: PubMed
    Score: 0.032
  10. Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. Cell Rep. 2020 07 14; 32(2):107908.
    View in: PubMed
    Score: 0.032
  11. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020 05; 26(5):769-780.
    View in: PubMed
    Score: 0.031
  12. Brain mural cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology. Neuropathol Appl Neurobiol. 2020 08; 46(5):458-477.
    View in: PubMed
    Score: 0.031
  13. Regulation of lifespan by neural excitation and REST. Nature. 2019 10; 574(7778):359-364.
    View in: PubMed
    Score: 0.030
  14. cindr, the Drosophila Homolog of the CD2AP Alzheimer's Disease Risk Gene, Is Required for Synaptic Transmission and Proteostasis. Cell Rep. 2019 08 13; 28(7):1799-1813.e5.
    View in: PubMed
    Score: 0.030
  15. Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects. Sci Rep. 2018 09 03; 8(1):13119.
    View in: PubMed
    Score: 0.028
  16. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology. J Clin Invest. 2018 10 01; 128(10):4297-4312.
    View in: PubMed
    Score: 0.028
  17. A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's Disease. Genetics. 2018 05; 209(1):51-64.
    View in: PubMed
    Score: 0.027
  18. A? mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci. 2018 01 31; 38(5):1085-1099.
    View in: PubMed
    Score: 0.027
  19. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of?Selective Neuronal Vulnerability. Stem Cell Reports. 2017 12 12; 9(6):1868-1884.
    View in: PubMed
    Score: 0.027
  20. Selective lowering of synapsins induced by oligomeric a-synuclein exacerbates memory deficits. Proc Natl Acad Sci U S A. 2017 06 06; 114(23):E4648-E4657.
    View in: PubMed
    Score: 0.026
  21. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease. Antioxid Redox Signal. 2017 Dec 01; 27(16):1269-1280.
    View in: PubMed
    Score: 0.026
  22. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample. Mol Neurodegener. 2017 03 20; 12(1):26.
    View in: PubMed
    Score: 0.025
  23. Soluble Conformers of A? and Tau Alter Selective Proteins Governing Axonal Transport. J Neurosci. 2016 09 14; 36(37):9647-58.
    View in: PubMed
    Score: 0.025
  24. Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense?oligonucleotides. EMBO Mol Med. 2016 04 01; 8(4):328-45.
    View in: PubMed
    Score: 0.024
  25. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. PLoS One. 2015; 10(10):e0139233.
    View in: PubMed
    Score: 0.023
  26. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet. 2015 Dec 01; 24(23):6721-35.
    View in: PubMed
    Score: 0.023
  27. Life extension factor klotho enhances cognition. Cell Rep. 2014 May 22; 7(4):1065-76.
    View in: PubMed
    Score: 0.021
  28. REST and stress resistance in ageing and Alzheimer's disease. Nature. 2014 03 27; 507(7493):448-54.
    View in: PubMed
    Score: 0.021
  29. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol. 2014 Apr; 254:78-89.
    View in: PubMed
    Score: 0.020
  30. Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment. Cell Death Differ. 2014 May; 21(5):696-706.
    View in: PubMed
    Score: 0.020
  31. PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and A?. J Neurosci. 2013 Jun 26; 33(26):10729-40.
    View in: PubMed
    Score: 0.020
  32. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013 Apr 25; 153(3):707-20.
    View in: PubMed
    Score: 0.019
  33. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.019
  34. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.018
  35. Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain. Synapse. 2011 Aug; 65(8):763-70.
    View in: PubMed
    Score: 0.017
  36. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009 Jan; 68(1):48-58.
    View in: PubMed
    Score: 0.014
  37. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron. 2008 Dec 26; 60(6):988-1009.
    View in: PubMed
    Score: 0.014
  38. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging. 2006 Nov; 27(11):1644-57.
    View in: PubMed
    Score: 0.012
  39. Mitochondrial DNA rearrangements in aging human brain and in situ PCR of mtDNA. Neurobiol Aging. 1999 Sep-Oct; 20(5):565-71.
    View in: PubMed
    Score: 0.008
  40. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther. 1987 Mar; 240(3):737-46.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.